Sensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicine

AAPS PharmSciTech

Volumn 13, Issue 1, 2012, Pages 202-210

  Agrahari, Vivek ^a   Youan, Bi Botti C ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

High performance liquid chromatography; Hyaluronic acid; Molar absorptivity; Nanomedicine; Tenofovir

Indexed keywords

ADEFOVIR; HYALURONIC ACID; TENOFOVIR;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); CROSS LINKING; DRUG ABSORPTION; DRUG PURIFICATION; DRUG RELEASE; DRUG RETENTION; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NANOMEDICINE; PH; PRIORITY JOURNAL; ZETA POTENTIAL;

ADENINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYALURONIC ACID; LIMIT OF DETECTION; NANOMEDICINE; ORGANOPHOSPHONATES; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84861099703     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9735-6     Document Type: Article

References (40)

1. Checa A, Oliver R, Hernández-Cassou S, Saurina J. Determination of HIV drugs in biological matrices: a review. Anal Chim Acta. 2009;647(1):1-13.
2. Zidan AS, Spinks C, Fortunak J, Habib M, Khan MA. Near-infrared investigations of novel anti-HIV tenofovir liposomes. AAPS J. 2010;12(2):202-14.
3. Choi SU, Bui T, Ho RJ. pH-Dependent interactions of indinavir and lipids in nanoparticles and their ibility to entrap a solute. J Pharm Sci. 2008;97(2):931-43. (Pubitemid 351293892)
4. Rohan LC, Sassi AB. Vaginal drug delivery systems for HIV prevention. AAPS J. 2009;11(1):78-87.
5. Ndesendo VM, Pillay V, Choonara YE, Buchmann E, Bayever DN, Meyer LC. A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. AAPS PharmSciTech. 2008;9(2):505-20.
6. D'Cruz OJ, Uckun FM. Clinical development of microbicides for the prevention of HIV infection. Curr Pharm Des. 2004;10 (3):315-36. (Pubitemid 38072766)
7. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168-74.
8. Rohan LC, Moncla BJ, Kunjara Na Ayudhya RP, Cost M, Huang Y, et al. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLoS One. 2010;5(2):1-13.
9. Alukda D, Sturgis T, Youan BB. Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention. J Pharm Sci. 2011;100(8):3345-56. doi:10.1002/jps.22529.
10. Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, et al. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS. 2006;20(4):543-51. (Pubitemid 43731598)
11. Rosen RK, Morrow KM, Carballo-Dieguez A, Mantell JE, Hoffman S, Gai F, et al. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study. J Womens Health (Larchmt). 2008;17(3):383-92. (Pubitemid 351457833)
12. Saxena BB, Han YA, Fu D, Rathnam P, Singh M, Laurence J, Lerner S. Sustained release of microbicides by newly engineered vaginal rings. AIDS. 2009;23(8):917-22.
13. Kandagal PB, Manjunatha DH, Seetharamappa J, Kalanur SS. RP-HPLC method for the determination of tenofovir in pharmaceutical formulations and spiked human plasma. Anal Lett. 2008;41(4):561-70. (Pubitemid 351465696)
14. Sentenac S, Fernandez C, Thuillier A, Lechat P, Aymard G. Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;793(2):317-24. (Pubitemid 37271971)
15. Jullien V, Tréluyer JM, Pons G, Rey E. Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;785(2):377-81. (Pubitemid 36126178)
16. Takahashi M, Kudaka Y, Okumura N, Hirano A, Banno K, Kaneda T. Determination of plasma tenofovir concentrations using a conventional LC-MS method. Biol Pharm Bull. 2007;30 (9):1784-6. (Pubitemid 47403239)
17. Yadav M, Mishra T, Singhal P, Goswami S, Shrivastav PS. Rapid and specific liquid chromatographic tandem mass spectrometric determination of tenofovir in human plasma and its fragmentation study. J Chromatogr Sci. 2009;47(2):140-8.
18. Delahunty T, Bushman L, Robbins B, Fletcher CV. The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877 (20-21):1907-14.
19. Bennetto-Hood C, Long MC, Acosta EP. Development of a sensitive and specific liquid chromatography/mass spectrometry method for the determination of tenofovir in human plasma. Rapid Commun Mass Spectrom. 2007;21(13):2087-94. (Pubitemid 46999262)
20. Raju NA. Simultaneous estimation of tenofovir disproxil fumerate, emtricitabine & efavirenz in tablet dosage forms by isocratic-RPHPLC. J Pharm Res. 2009;2(6):1103-6.
21. Rezk NL, Crutchley RD, Kashuba AD. Simultaneous quantification of emtricitabine and tenofovir in human plasma using highperformance liquid chromatography after solid phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;822(1-2):201-8. (Pubitemid 40994053)
22. Sun D, Wang H, Wang B, Guo R. Development and validation of a sensitive LC-MS/MS method for the determination of adefovir in human serum and urine. J Pharm Biomed Anal. 2006;42(3):372-8. (Pubitemid 44310897)
23. Huidobro AL, Rupérez FJ, Barbas C. LC methods for acyclovir and related impurities determination. J Pharm Biomed Anal. 2005;37(4):687-94. (Pubitemid 40417741)
24. Choi KY, Chung H, Min KH, Yoon HY, Kim K, Park JH, Kwon IC, Jeong SY. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials. 2010;31(1):106-14.
25. Al-Ghananeem AM, Malkawi AH, Muammer YM, Balko JM, Black EP, Mourad W, et al. Intratumoral delivery of Paclitaxel in solid tumor from biodegradable hyaluronan nanoparticles formulations. AAPS PharmSciTech. 2009;10(2):410-7.
26. Carole E, Schanté GZ, Herlin C, Vandamme TF. Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohyd Polym. 2011;85(3):469-89.
27. Swyer GI. The hyaluronidase content of semen. Biochem J. 1947;41(3):409-13.
28. Nirogi RVS, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Boosi R, et al. Sensitive and selective liquid chromatography-tandem mass spectrometry method for the quantification of azithromycin in human plasma. Anal Chim Acta. 2005;553(1-2):1-8. (Pubitemid 41503498)
29. Khan A, Khan MI, Iqbal Z, Shah Y, Ahmad L, Watson DG. An optimized and validated RP-HPLC/UV detection method for simultaneous determination of all-trans-retinol (vitamin A) and alpha-tocopherol (vitamin E) in human serum: comparison of different particulate reversed-phase HPLC columns. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878 (25):2339-47.
30. Xu M, Ju W, Xia X, Tan H, Chen M, Zhang J, et al. Determination of rimantadine in rat plasma by liquid chromatography/electrospray mass spectrometry and its application in a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;864(1-2):123-8.
31. Liebhafsky HA, Pfeiffer HG. Beer's law in analytical chemistry. J Chem Educ. 1953;30(9):450-2.
32. ICH Guideline. Q2 (R1). Validation of analytical procedures: text and methodology. Geneva Switzerland: ICH Secretariat; 2005.
33. Pelillo M, Cuvelier ME, Biguzzi B, Gallina Toschi T, Berset C, Lercker G. Calculation of the molar absorptivity of polyphenols by using liquid chromatography with diode array detection: the case of carnosic acid. J Chromatogr A. 2004;1023 (2):225-9. (Pubitemid 37494795)
34. Hu Z, Xia X, Tang L (inventors). Process for synthesizing oil and surfactant-free hyaluronic acid nanoparticles and microparticles. United States patent 7,601,704 B2. 2009 October 13.
35. Hackley V, Ferraris C. The use of nomenclature in dispersion science and technology, NIST Recommended Practice Guide. NIST SP. 2001; 960-3; 72; SP
36. Romero-Pérez A, García-García E, Zavaleta-Mancera A, Ramírez-Bribiesca JE, Revilla-Vázquez A, Hernández-Calva LM, et al. Designing and evaluation of sodium selenite nanoparticles in vitro to improve selenium absorption in ruminants. Vet Res Commun. 2010;34(1):71-9.
37. Owen DH, Katz DF. A review of the physical and chemical properties of human semen and the formulation of a semen simulant. J Androl. 2005;26(4):459-69. (Pubitemid 40847857)
38. Owen DH, Katz DF. A vaginal fluid simulant. Contraception. 1999;59(2):91-5. (Pubitemid 29244754)
39. Patel S, Baghel US, Rajesh P, Prabhakar D, Engla G, Nagar PN. Spectrophotometric method development and validation for simultaneous estimation of tenofovir disoproxil fumarate and emtricitabine in bulk drug and tablet dosage form. Int J Pharm Clin Res. 2009;1:28-30.
40. O'Neil MJ, Smith A, Heckelman PE. The Merck index. 13th ed. New Jersey: Merck research laboratories; 2001.